Join our daily newsletter At The Bell to receive exclusive market insights
- Novita Healthcare’s (ASX:NHL) “TALi” educational platform will gain a big boost in funding
- The educational tool made for children struggling with attention disorders and autism is at the centre of a $6.2 million fund raising
- Shares offered at a strong discount of $0.062 each gained commitments from investors
- The hefty funding will be mostly used to progress its marketing and sales in the American market
- Novita has said today its also interested in applying TALi towards additional neurological areas of learning — although unspecified
- Novita came off a trading halt today, trading higher by 2.9 per cent for 7.1 cents each
Novita Healthcare’s education tool for children struggling to stay focused during class-time is at the centre of a multi-million-dollar raising.
The company is posed to net $6.2 million from a share placement after it came off a trading halt from last week.
Shares were offered at a a huge discount at $0.062 each — with investors signalling the commitment for 10 million options to be bought up.
The purchase opportunity is a 10 per cent discount from the last closing price of 6.9 cents, as well as a 24.5 per cent discount from the last 15 days.
Novita flagged to punters today that the funds will mostly be used to boost marketing and sales of its training tool, TALi, in the U.S.
A lesser portion of funding will also be used for similar commercial activities in Australia, Europe, and the U.K.
Most interestingly, Novita also said it has interest to apply TALi for other undisclosed neurological areas of development.
Image sourced from Novita Healthcare
The TALi train platform is an educational tool wholly-focused on children with attention disorders — such as those with ADD and Autism.
TALi uses games that promote learning for children that are fun to play.
The game-based exercises on the platform contribute for 20-minute sessions of education and fun for the users.
Novita Healthcare went into a trading halt last week for its share placement raise. Since resuming trading, shares have gained 2.9 per cent for a value of 7.1 cents each.
